In humans, circulating calprotectin levels are significantly higher in obese individuals, correlate with body mass, fat content, CRP, indicators of insulin resistance [12] and are associated with diabetes, hypertension, poorer glycemic control, unfavorable lipid profile and increased risk of atherosclerotic cardiovascular disease [14]. Here, CRP is linked to Insulin resistance.